NCT04577534View on ClinicalTrials.gov

COVID-19: Salvage TOcilizumab as a Rescue Measure

PHASE3CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

August 14, 2020

Primary Completion Date

June 16, 2021

Study Completion Date

June 16, 2021

Conditions
Covid19
Interventions
DRUG

iv Tocillizumab (TCZ)

Participants are randomized (2:1) to receive TCZ or Standard of Care

Trial Locations (1)

20521

Turku University Hospital, Turku

All Listed Sponsors
lead

Jarmo Oksi

OTHER_GOV

NCT04577534 - COVID-19: Salvage TOcilizumab as a Rescue Measure | Biotech Hunter | Biotech Hunter